Tag: carboplatin–paclitaxel

Niraparib may lengthen progression-free survival for patients with recurrent ovarian cancer

Retifanlimab improves progression-free survival in advanced squamous cell anal carcinoma

byNeel Mistryand1 others

July 24, 2025

1. Progression-free survival was significantly greater in retifanlimab compared to placebo. 2. Serious and grade 3 or more adverse events ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

Increased rates of unmet social needs observed shortly following a diagnosis of dementia
Retifanlimab improves progression-free survival in advanced squamous cell anal carcinoma
Bedtime dosing of antihypertensive medications may provide improved outcomes over morning dosing

No Result

View All Result